Ironwood Pharmaceuticals, Inc. (IRWD) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 546.66M |
| Enterprise Value | 929.01M |
| P/E Ratio | 5.57 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 1.61 |
| Price/Book Ratio | -2.66 |
| Enterprise/Revenue | 2.65 |
| Enterprise/EBITDA | 4.63 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.28 |
| Operating Margin | 0.56 |
AD
Management Effectiveness
| Return On Assets | 0.24 |
| Return On Equity | -0.39 |
Income Statement
| Revenue | 296.15M |
| Revenue/Share | 2.21 |
| Gross Profit | 296.15M |
| EBITDA | 104.65M |
| Net Income | 24.02M |
| Diluted EPS | 0.15 |
Balance Sheet
| Total Cash | 220.47M |
| Total Cash/Share | 1.35 |
| Total Debt | 597.36M |
| Total Debt/Equity | -2.75 |
| Current Ratio | 1.41 |
| Book Value Per Share | -1.33 |
Price History
| 52-Week Change | 425.69 |
| 52-Week High | 5.78 |
| 52-Week Low | 0.66 |
| Moving Average 50 Days | 3.86 |
| Moving Average 200 Days | 3.26 |
Statistics
| Average Volume | 2.19M |
| Shares Outstanding | 164.61M |
| % Held by Institutions | 99.53 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 597:500 |
| Last Split Date | April 02, 2019 |
AD
